Company / Working Capital
Tonix Pharmaceuticals Holding Corp. Working Capital History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$198.0M
FY2025
5-year range
$28.9M / $198.0M
FY2023-FY2025
Trend
+96.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $29M to $198M over the past 2 years.
Based on SEC 10-K filings.
$198M in FY2025.
Improved from $29M to $198M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, working capital increased 96.7% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $198.0M | +96.7% |
| FY2024 | $100.7M | +248.6% |
| FY2023 | $28.9M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 28, 2026